ETFMG Treatments Testing and Advancements ETF (GERM) ETF Holdings & Portfolio Analysis - Complete Fund Breakdown - Stocknear

ETFMG Treatments Testing ...

AMEX: GERM · Real-Time Price · USD
19.16
-0.05 (-0.28%)
At close: Sep 05, 2024, 9:53 PM

GERM Holdings List

As of Aug 11, 2024
The ETFMG Treatments Testing and Advancements ETF is an equity ETF with a total of 52 individual holdings. The top holdings are Alnylam Pharmaceuticals at 11.39%, Labcorp s at 7.20%, Quest Diagnostics Incorporated at 6.61%, BioNTech SE at 5.01%, and Bio-Rad Laboratories at 4.74%.
52
54.55%
Equity
9.68M
7.45
0.6800%

Sector Allocation

Rank Symbol Name Price % Change Shares % Weight
1 ALNY Alnylam Pharmac...
447.49
+0.24% 3.96K 11.39%
2 LH Labcorp Holding...
282.77
+0.77% 2.98K 7.20%
3 DGX Quest Diagnosti...
188.89
-0.05% 4.14K 6.61%
4 BNTX BioNTech SE
98.10
+0.02% 5.8K 5.01%
5 BIO Bio-Rad Laborat...
270.12
-0.46% 1.36K 4.74%
6 PCVX Vaxcyte, Inc.
34.65
+1.97% 5.43K 4.52%
7 QDEL QuidelOrtho Cor...
28.88
+1.94% 9.25K 4.11%
8 BCRX BioCryst Pharma...
7.55
-1.05% 45.43K 3.70%
9 IMCR Immunocore Hold...
34.34
+0.94% 9.23K 3.67%
10 ZLAB Zai Lab Limited
32.93
+4.14% 20.73K 3.60%
11 MRNA Moderna, Inc.
25.33
+3.43% 3.82K 3.46%
12 DVAX Dynavax Technol...
9.66
-1.23% 28.81K 3.42%
13 IBRX ImmunityBio, In...
2.57
+1.18% 64.67K 3.14%
14 VIR Vir Biotechnolo...
5.63
+2.55% 29.95K 2.79%
15 NVAX Novavax, Inc.
8.57
+0.23% 20.14K 2.50%
16 OPK OPKO Health, In...
1.47
+1.38% 153.42K 2.46%
17 CVAC CureVac N.V.
5.35
-0.37% 49.37K 1.73%
18 FLGT Fulgent Genetic...
22.30
-1.28% 6.59K 1.68%
19 ABUS Arbutus Biophar...
4.46
+1.13% 41.54K 1.62%
20 ADPT Adaptive Biotec...
13.46
+1.82% 32.44K 1.55%
Page 1 of 3